0001415889-24-005996.txt : 20240229
0001415889-24-005996.hdr.sgml : 20240229
20240229193301
ACCESSION NUMBER: 0001415889-24-005996
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240227
FILED AS OF DATE: 20240229
DATE AS OF CHANGE: 20240229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: AKKARAJU SRINIVAS
CENTRAL INDEX KEY: 0001253170
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37524
FILM NUMBER: 24706297
MAIL ADDRESS:
STREET 1: 565 EVERETT AVENUE
CITY: PALO ALTO
STATE: CA
ZIP: 94301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: vTv Therapeutics Inc.
CENTRAL INDEX KEY: 0001641489
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 473916571
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3980 PREMIER DR
STREET 2: SUITE 310
CITY: HIGH POINT
STATE: NC
ZIP: 27265
BUSINESS PHONE: 336-841-0300
MAIL ADDRESS:
STREET 1: 3980 PREMIER DR
STREET 2: SUITE 310
CITY: HIGH POINT
STATE: NC
ZIP: 27265
FORMER COMPANY:
FORMER CONFORMED NAME: VTV Therapeutics Inc.
DATE OF NAME CHANGE: 20150506
4
1
form4-03012024_120353.xml
X0508
4
2024-02-27
0001641489
vTv Therapeutics Inc.
VTVT
0001253170
AKKARAJU SRINIVAS
C/O VTV THERAPEUTICS INC.
3980 PREMIER DRIVE, SUITE 310
HIGH POINT
NC
27265
true
false
true
false
0
Class A Common Stock
2024-02-27
4
A
0
224732
11.81
A
265620
I
By Samsara BioCapital, L.P.
Pre- Funded Warrants (Right to Buy)
0.01
2024-02-27
4
A
0
833693
11.80
A
Class A Common Stock
833693
833693
I
Samsara BioCapital, L.P.
These securities are held by Samsara BioCapital, L.P. ("Samsara LP"). Samsara BioCapital GP, LLC ("Samsara LLC") is the general partner of Samsara LP and may be deemed to beneficially own the securities held by Samsara LP. The Reporting Person has voting and investment power over the securities held by Samsara LP and, accordingly, may be deemed to beneficially own the securities held by Samsara LP. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein.
The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 9.99% of the number of shares of Class A Common Stock outstanding immediately after giving effect to such exercise.
/s/ Srinivas Akkaraju
2024-02-29